Drug containing active sulfur compound as its main component
AssigneesTohoku University, Bio-Xcelerator, Inc.
InventorsTakaaki AKAIKE, Satoshi TAKAGI, Hisatoshi SUGIURA, Kenji INABA
Life of this patent
Estimating the term…
Abstract
There is provided a drug which exhibits preventive and therapeutic effects on virus infectious diseases by inhibiting virus-derived protease on the basis of various physiological activity actions of an active sulfur compound(s) which exists in living organisms.
Claims17
An antiviral drug containing an active sulfur compound as its main medical efficacy component.
A preventive and therapeutic drug for a novel coronavirus infection (COVID-19), the drug containing glutathione trisulfide (GSSSG) as its main medical efficacy component.
An immune control agent (adjuster) containing glutathione trisulfide (GSSSG) as its main medical efficacy component.
An anti-inflammatory drug containing glutathione trisulfide (GSSSG) as its main medical efficacy component.
A preventive and therapeutic drug for viral pneumonia, the drug containing an active sulfur compound as its main component.
Dependencies are inferred from the claim text.